A Surrogate Endpoint Based Provisional Approval Causal Roadmap

Peter B. Gilbert, James Peng, Larry Han +12

For many rare diseases with no approved preventive interventions, promising interventions exist, yet it has been difficult to conduct a pivotal phase 3 trial that could provide dir…